A genome-wide cross-trait analysis characterises the shared genetic architecture between rheumatoid arthritis and psychiatric disorders.

Authors

Xin Ke, Shi Yao, Xi Zheng, Hao Wu, Tian-Yue Liu, Feng-Fan Yang, Kui Zhang, Zhao-Hui Zheng, Ping Zhu

Published in

Rheumatology (Oxford, England). Jul 29, 2026. Epub Jul 29, 2026.

Abstract

Patients with rheumatoid arthritis (RA) have a 2- to 3-fold elevated risk of psychiatric disorders, suggesting an underlying genetic link between these phenotypes. However, the shared genetic architectures and pathological mechanisms driving RA-psychiatric disorder comorbidity remain to be fully elucidated. Herein, we performed cross-trait analysis to investigate the shared genetic architecture between RA and psychiatric disorders.
Leveraging European-ancestry genome-wide association studies (GWASs) datasets of RA (N = 1,026,690) and ten major psychiatric disorders (N = 14,307 to 1,222,882), we performed cross-trait pleiotropic analysis to identify the shared pleiotropic loci and genes between RA and psychiatric disorders, followed by functional annotation and Mendelian randomization analysis to explore the pathological mechanisms underlying RA-psychiatric disorder comorbidity.
Our analysis revealed significant positive genetic correlations between RA and seven psychiatric disorders, such as major depressive disorder. From these correlations, we identified 61 pleiotropic loci jointly influencing RA and psychiatric disorder risk, along with 208 pleiotropic genes predominantly involved in immune and inflammatory response biological processes. Druggable target exploration identified 21 drug-gene interactions involving pleiotropic genes, with two genes (RHOA and TRAF3) classified as clinically actionable category, representing potential therapeutic target for both RA and psychiatric disorders. Mendelian randomization further demonstrated a bidirectional causal relationship between RA and SCZ, while supporting the causal roles of ADHD, MDD, and PTSD in increasing RA risk.
Our findings elucidate the shared genetic architecture between RA and psychiatric disorders, providing novel insights into the pathological mechanisms underlying their comorbidity and laying groundwork for improved comorbidity management.

PMID:
42525381
Bibliographic data and abstract were imported from PubMed on 29 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.